USP24 stabilizes VDAC2 via deubiquitination to promote apoptosis and ferroptosis in clear cell renal cell carcinoma (ccRCC)

Authors:

Abstract
Objectives: Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer, and its pathogenesis is closely associated with dysregulated cell death. This study aims to elucidate the role of the ubiquitin-specific protease 24 (USP24) in ccRCC progression and its molecular mechanisms. Methods: Multi-omics data from the TCGA, GEO, and HPA databases were integrated to analyse USP24 expression levels and their clinical significance in ccRCC. The specific mechanism of interaction between USP24 and voltage-dependent anion channel 2 (VDAC2) was validated through co-immunoprecipitation, mass spectrometry analysis, molecular docking, and site-directed mutagenesis. In vitro functional assays – including deubiquitination assays, flow cytometry analysis of apoptosis, and assessment of ferroptosis-related markers – verified USP24’s inhibitory effect on ccRCC. Results: USP24 was significantly downregulated in ccRCC tissues and cell lines, with its low expression correlated with poor patient prognosis (hazard ratio [HR]=0.57, p<0.001), suggesting its potential utility as a prognostic indicator. Mechanistic studies revealed that USP24 directly binds VDAC2 and removes its ubiquitinylation at position 277, thereby stabilizing the VDAC2 protein. This stabilizing effect promotes apoptosis and ferroptosis in ccRCC cells, and reactivating this pathway may serve as a viable therapeutic strategy for ccRCC. Single-cell RNA sequencing analysis further confirmed the co-expression of USP24 and VDAC2 in renal tubular epithelial cells. Conclusions: This study reveals that the USP24-VDAC2 axis exerts key tumour-suppressive functions by promoting apoptosis and ferroptosis, thereby inhibiting ccRCC progression. Targeting this axis may provide novel therapeutic strategies for ccRCC.
Funding Information
  • Weifang Science and Technology Development Plan Project (2025YX032)
  • Natural Science Foundation of Shandong Province (ZR2024MH161)
  • China Postdoctoral Science Foundation (2023M742311)
  • The Innovation and Entrepreneurship Training Program for Students of Shandong Second Medical University (X2025035, X2025064 and X2025065)

This publication has 58 references indexed in Scilit: